Novel Parasiticide

About Virbac SA

Virbac SA is a mission-driven, independent leader in the global animal health market, focused on delivering practical and innovative health solutions for veterinarians, farmers, and pet owners. Founded in 1968, it has grown into the world's sixth-largest veterinary drug manufacturer, achieving €1.465 billion in 2025 sales with a robust 7.9% organic growth rate. Its strategy is built on a diversified portfolio across pharmaceuticals, vaccines, and nutrition, sustained R&D investment, and a strong ESG profile, all underpinned by a founding-family-controlled governance that ensures long-term vision and cultural consistency.

Therapeutic Areas